fda compounding semaglutide crackdown news today 2025 proposes a new GLP-1 🚨 FDA Moves to Permanently

[15] Liang Y, Xu X, Yin M, et al

At the 12 mg dose: 28.3% average weight loss (about 70 lbs) 45.3% of patients lost 30% or more of their body weight 65.3% of patients dropped below a BMI of 30 Patients with baseline BMI 35 who stayed for 104 weeks lost 30.3% on average (85 lbs), with no plateau in sight Discontinuation due to side effects: 11.3% at 12 mg vs

Slightly less interest in snacking between meals

In 2024, according to GoodRx, out-of-pocket cost for the most common injectable weight loss medications (Zepbound, Saxenda, Wegovy, and Ozempic) averaged from $950 to $2,000 USD per month

Some research suggests tirzepatide users may experience fewer severe GI side effects than expected given its dual mechanism, but responses are highly individual

A doctor will show you how